Phytoestrogens are the natural compounds isolated from plants, which are structurally similar to animal
estrogen, 17beta-estradiol.
Tectoridin, a major
isoflavone isolated from the rhizome of Belamcanda chinensis.
Tectoridin is known as a
phytoestrogen, however, the molecular mechanisms underlying its
estrogenic effect are remained unclear. In this study we investigated the estrogenic signaling triggered by
tectoridin as compared to a famous
phytoestrogen,
genistein in MCF-7 human
breast cancer cells.
Tectoridin scarcely binds to ER alpha as compared to 17beta-estradiol and
genistein. Despite poor binding to ER alpha,
tectoridin induced potent
estrogenic effects, namely recovery of the population of cells in the S-phase after serum
starvation, transactivation of the
estrogen response element, and induction of MCF-7 cell proliferation. The
tectoridin-induced
estrogenic effect was severely abrogated by treatment with
U0126, a specific MEK1/2 inhibitor.
Tectoridin promoted phosphorylation of ERK1/2, but did not affect phosphorylation of ER alpha at Ser(118). It also increased cellular accumulation of cAMP, a hallmark of GPR30-mediated
estrogen signaling. These data imply that
tectoridin exerts its
estrogenic effect mainly via the GPR30 and ERK-mediated rapid nongenomic
estrogen signaling pathway. This property of
tectoridin sets it aside from
genistein where it exerts the
estrogenic effects via both an ER-dependent genomic pathway and a GPR30-dependent nongenomic pathway.